A Phase II Platform Study to Evaluate Treatment with Cemiplimab Monotherapy or Cemiplimab plus Fianlimab or Other Novel Combinations in Patients with Colorectal Cancer with Minimal Residual Disease Following Definitive Surgery and Chemotherapy EMPIRE

Brief Summary

Type:
Colon

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT07058012

Study #:
STUDY00162058

Start Date:
Jun 04, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT07058012

View Complete Trial Details & Eligibility at ClinicalTrials.gov